SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040540
Filing Date
2023-11-13
Accepted
2023-11-13 16:26:51
Documents
69
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 920276
2 ex31-1.htm EX-31.1 23109
3 ex31-2.htm EX-31.2 21436
4 ex32-1.htm EX-32.1 7986
5 ex32-2.htm EX-32.2 8182
  Complete submission text file 0001493152-23-040540.txt   4646163

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE cing-20230930.xsd EX-101.SCH 39726
7 XBRL CALCULATION FILE cing-20230930_cal.xml EX-101.CAL 58551
8 XBRL DEFINITION FILE cing-20230930_def.xml EX-101.DEF 157804
9 XBRL LABEL FILE cing-20230930_lab.xml EX-101.LAB 297959
10 XBRL PRESENTATION FILE cing-20230930_pre.xml EX-101.PRE 241354
63 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 610575
Mailing Address 1901 W. 47TH PLACE KANSAS CITY KS 66205
Business Address 1901 W. 47TH PLACE KANSAS CITY KS 66205 (913) 942-2300
Cingulate Inc. (Filer) CIK: 0001862150 (see all company filings)

IRS No.: 863825535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40874 | Film No.: 231399208
SIC: 2834 Pharmaceutical Preparations